Highest-materiality recent filing
JBT Marel shareholders elect all 10 directors, approve say-on-pay and auditor ratification
All 10 director nominees elected; highest 'against' votes were 1.6M for Polly B. Kawalek.
JBT Marel declares $0.10 dividend, authorizes $200M buyback effective May 18
Quarterly dividend of $0.10 per share, payable June 9, 2026 to holders of record May 26, 2026.
JBT Marel authorizes $200M share repurchase program and declares $0.10 quarterly dividend
Board authorized up to $200M share repurchase program effective June 1, 2026 through May 31, 2029.
JBT Marel Q1 revenue $936M (+10% YoY), EPS $0.86, adj. EPS $1.58; reiterates FY2026 outlook
Orders totaled $1.07B, book-to-bill 1.14x; revenue $936M (+10% YoY, ~6% FX benefit).
JBT Marel Investor Day: 2025 revenue $3.8B, Adj EBITDA 15.8%, targets 5-7% annual growth
2025 revenue $3.8B, adjusted EBITDA margin 15.8%; expects 5-7% annual revenue CAGR over 3 years.
JBT Marel reports FY2025 revenue $3.8B, adj. EBITDA $600M; guides FY2026 growth 5-7%
FY2025 revenue $3.8B, record Q4 revenue exceeding $1.0B; adjusted EBITDA $600M (15.8% margin).
JBT Marel realigns segments into Protein Solutions and Prepared Food & Beverage Solutions
New segments replace prior JBT/Marel structure, effective Q4 2025, with recast historical data.
JBT Marel Q3 adj. EPS $1.94 beats; raises FY2025 revenue and EPS guidance
Q3 revenue $1.0B, adj. EBITDA $171M (17.1% margin), adj. EPS $1.94; orders $946M.
JBT Marel Corp CAO Jessi Corcoran resigns; CFO Meister appointed as principal accounting officer
Jessi L. Corcoran, VP, Corporate Controller and CAO, resigned effective Nov 4, 2025; she accepted a role at another company.
JBT Marel closes $575M 0.375% convertible notes due 2030; net proceeds ~$506M
$575M aggregate principal (incl. $75M greenshoe) of 0.375% convertible senior notes due 2030.
JBT Marel launches $500M convertible notes offering; amends credit facility to lower borrowing costs
Offering of $500M convertible senior notes due 2030 (plus $75M option) to QIBs under Rule 144A.
JBT Marel reduces Term Loan pricing by 25-75 bps via $897.75M refinancing
First Amendment reduces Term B Loan margin from SOFR+2.00%-2.50% to SOFR+1.75%, removes 10 bps credit spread.
JBT Marel Reports Q2 2025 Results, Exceeds Guidance, Re-establishes Full Year Forecast
Q2 revenue $935M, orders $938M, backlog $1.4B, with over half revenue from recurring sources.
JBT Marel stockholders re-elect three directors, approve advisory pay vote, ratify auditor
Alan D. Feldman, Lawrence V. Jackson, Ann E. Savage re-elected to Board with over 37.5M votes each.
JBT Marel Q1 net loss $173M; adj EPS $0.97; suspends FY guidance on tariff uncertainty
Revenue $854M, net loss from continuing ops $173M, GAAP EPS $(3.35); adjusted EPS $0.97.
JBT Marel CLO James L. Marvin to retire May 31, 2025; successor search underway
James L. Marvin, Executive VP and Chief Legal Officer, to retire on May 31, 2025.
Marel 2024 revenue EUR 1.64B, net loss EUR 25M vs prior year profit
Revenue of EUR 1,642.7 million, down 4.6% YoY from EUR 1,721.4M.
JBT Marel posts Q4 record orders; raises cost synergies to $150M; guides FY25 adj EPS $5.50-6.10
JBT standalone Q4 record orders $523M; FY24 revenue $1,716M (+3%), adj EBITDA $295M (+8%).
JBT Marel completes compulsory acquisition of remaining Marel shares
Compulsory acquisition closed Feb 4, 2025; remaining Marel shareholders received ~EUR 23.6M cash and 493,150 JBT Marel shares.
JBT Marel files pro forma financials for Marel deal; combined net loss $41M in FY2023
Marel holders representing 97.5% of shares accepted; squeeze-out redemption period ends Jan 30, 2025.
JBT Marel completes acquisition of Marel hf.; issues ~19.5M shares, pays ~EUR 927M cash
Achieved 97.5% acceptance; Marel shareholders received EUR 926.6M cash and 19.5M JBTM shares.
JBT achieves 97.5% Marel shareholder acceptance, will complete acquisition Jan 2, 2025
Marel shareholders tendered 735.3M shares (97.5%), exceeding the 90% minimum acceptance condition.
JBT receives all regulatory clearances for Marel acquisition; offer expires Dec 20, 2024
European Commission cleared transaction on Nov 26, 2024 after Phase 1 review.
Marel 9M 2024 revenue EUR 1,214.7M (-4.6% YoY); net profit EUR 2.7M vs EUR 22.3M a year earlier.
JBT extends Marel takeover offer to Dec 20 for regulatory reviews
Offer extended from Nov 11 to Dec 20, 2024; E.C. Phase 1 review ends Nov 28.
JBT Q3 revenue $454M (+12%), adj. EPS $1.50 (+35%), reiterates FY 2024 guidance
Q3 income from continuing ops $38M (+23%); diluted EPS $1.18 (+22%).
JBT extends Marel takeover offer deadline to Nov 11, 2024 or 3 weeks post regulatory clearances
Offer expiration extended from Sept 2 to earlier of Nov 11, 2024 or three weeks after all regulatory clearances secured.
JBT provides Marel H1 2024 financials and pro forma combined data for takeover
Marel H1 2024 revenue €827.8M vs €869.8M YoY; net loss €1.1M vs profit €12.2M.
JBT shareholders approve stock issuance for Marel acquisition; over 30M votes in favor
Special meeting on Aug 8, 2024; 30,077,405 shares (94.5% of outstanding) present.
JBT supplements Marel deal proxy disclosures to moot shareholder lawsuit
Lawsuit filed July 18 in Illinois claims proxy omits material info; seeks injunction against Aug 8 stockholder vote.
JBT awards EVP Rizzolo $75K assignment bonus, $250K success bonus for Marel integration
Compensation Committee approved $75,000 cash assignment bonus for Augusto Rizzolo, payable August 2024.
JBT Q2 revenue $402M (-6% YoY), EPS $0.95; Marel combination progressing, offer expires Sept 2
Q2 revenue $402M (-6% YoY); income from cont ops $31M (+8%); GAAP EPS $0.95 (+7%), adj EPS $1.05 (+8%).
JBT amends 8-K to add inline XBRL financials; 2021 balance sheet recast for AeroTech sale
Amendment provides inline XBRL-tagged audited financial statements for 2023, 2022, and 2021.
JBT files audited financials for 2021-2023 in support of Marel takeover offer
FY 2023 revenue $1.66B (+5% YoY); operating income $164.7M vs $132.6M in 2022.
JBT amends $1.3B credit facility to permit Marel takeover offer
Second Amendment to existing $1.3B revolving credit agreement executed May 17, 2024.
JBT shareholders re-elect directors, approve say-on-pay, ratify auditor at annual meeting
C. Maury Devine re-elected with 28.5M votes for, 1.3M against; Charles L. Harrington re-elected with 29.5M for, 0.2M against.
Q1 revenue $392M (+1% YoY); GAAP EPS $0.71 (+34%); adjusted EPS $0.85 (+39%).
Offer: €3.60/share cash, 0.0407 JBT shares, or combination (65% stock/35% cash mix); Marel shareholders receive ~€950M cash and 38% of combined company.
Offer price EUR 3.60 per share cash, or 0.0407 JBT shares; total cash ~EUR 950M; Marel shareholders get ~38% of combined co.
Director Emmanuel Lagarrigue resigns from JBT board; board size reduced to 7
Emmanuel Lagarrigue resigned from JBT's Board effective February 27, 2024.
JBT Q4 EPS $1.64 (+69%); adj EPS $1.40; FY adj EBITDA margin 16.4%; Marel offer €3.60
Q4 revenue $445M (+1%); net income $53M (+69%); adjusted EBITDA $81M, margin 18.2% (+260 bps).
JBT to acquire Marel at €3.60 per share, valuing Marel equity at ~€2.7B and enterprise value at ~€3.5B (incl. net debt).
JBT receives extension to Jan 19 for Marel takeover offer decision
Deadline extended from Jan 5 to Jan 19, 2024 by FSA of Central Bank of Iceland.
JBT proposes €3.40/share acquisition of Marel hf, 46% premium, ~€3.4B EV
JBT submitted enhanced €3.40 per share offer (ISK511) for Marel; 46% premium to Nov 23, 2023 unaffected price.
JBT confirms non-binding proposal to acquire Marel; Eyrir Invest with 24.7% supports exclusivity
JBT submitted non-binding initial proposal to acquire all shares of Marel hf., listed on Nasdaq Iceland and Euronext Amsterdam.
Income from continuing ops $31M, EPS $0.95 (+19%); adjusted EPS $1.11 (+16%).
JBT Q2 continuing ops adj. EPS $0.97 beat implied guidance; AeroTech sale closed for $800M
Revenue from continuing ops $428M (+9% YoY); income $28M; adjusted EBITDA $71M (+34%) with margin 16.7%.
JBT gets lender consent for AeroTech sale to Oshkosh; subsidiary guarantors released
Limited Consent entered June 9, 2023, gives lenders' approval for JBT's sale of AeroTech subsidiary to Oshkosh Corporation.
JBT sells AeroTech to Oshkosh for $800M cash; expects Q3 2023 close
All-cash sale valued at $800M; multiple ~14.7x trailing 4Q adjusted EBITDA as of March 31, 2023.
JBT shareholders approve phased board declassification by 2026; annual meeting results
Board declassification approved: fully declassified by 2026 annual meeting; Certificate of Incorporation amended May 15, 2023.
James L. Marvin, the Executive Vice President and Chief Legal Officer of JBT Marel Corporation (the “Company”), announced his intention to retire on May 31, 2025.
C. Maury Devine resigned from the Company’s Board of Directors (the “Board”).
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
appointed Svafa Gronfeldt, Olafur S. Gudmundsson, Arnar Thor Masson and Ann Savage (collectively, the “New Directors”) to the Board
On the Closing Date, Arni Sigurdsson was appointed as President of the Company.
On February 27, 2024, Emmanuel Lagarrigue, a member of the Board of Directors (the “Board”) of John Bean Technologies Corporation (the “Company”) and the Board’s Audit Committee and Governance and Sustainability Committee, resigned from the Board effective as of February 27, 2024.
On August 16, 2022, the Board of Directors of the Company appointed Luiz “Augusto” Rizzolo to serve as the Company’s Executive Vice President, President Diversified Food & Health, effective October 1, 2022.
On August 15, 2022, Carlos Fernandez, Executive Vice President, President Diversified Food & Health, of John Bean Technologies Corporation (the “Company”) resigned from such position, effective October 1, 2022.
James E. Goodwin, former Chairman and CEO of UAL Corporation, will also retire from the Board at the Company’s Annual Meeting of Stockholders in May in accordance with the Company’s Board retirement policy.
James M. Ringler, a member of the Company’s original Board, determined that he will retire from the Board effective at the May 2022 Annual Meeting of Stockholders.
Max materiality 0.90 · Median 0.70 · Most common event m_and_a